In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against taenia solium

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 2, 2013, Pages 944-949

  Paredes, Adriana ^a   De Campos Lourenco, Tiago ^b   Marzal, Miguel ^b   Rivera, Andrea ^a   Dorny, Pierre ^b   Mahanty, Siddhartha ^a,c   Guerra Giraldez, Cristina ^a,b,e   García, Hector H ^a,d   Cass, Theodore E ^a,b   Cass, Quezia B ^b  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE SULFOXIDE; ALKALINE PHOSPHATASE; PARASITE ANTIGEN; PRAZIQUANTEL;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYST (RESTING STAGE); ENANTIOMER; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; SUPERNATANT; SWINE; TAENIA SOLIUM; TAENIASIS; TIME;

ALBENDAZOLE; ALKALINE PHOSPHATASE; ANIMALS; ANTICESTODAL AGENTS; NEUROCYSTICERCOSIS; PRAZIQUANTEL; STEREOISOMERISM; SWINE; TAENIA SOLIUM;

EID: 84872851085     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01465-12     Document Type: Article

References (30)

1. García HH, Gonzalez AE, Evans CA, Gilman RH. 2003. Taenia solium cysticercosis. Lancet 362:547-556.
2. Del Brutto OH, Roos KL, Coffey CS, Garcia HH. 2006. Meta-analysis: Cysticidal drugs for neurocysticercosis: Albendazole and praziquantel. Ann. Intern. Med. 145:43-51.
3. GarcíA HH, Evans CA, Nash TE, Takayanagui OM, White AC, Jr, Botero D, Rajshekhar V, Tsang VC, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez AE, Gilman RH, Del Brutto OH. 2002. Current consensus guidelines for treatment of neurocysticercosis. Clin. Microbiol. Rev. 15:747-756.
4. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proano JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH. 2006. Treatment of neurocysticercosis: Current status and future research needs. Neurology 67:1120-1127.
5. Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, Hauser WA. 2008. Effects of albendazole treatment on neurocysticercosis: A randomised controlled trial. J. Neurol. Neurosurg. Psychiatry 79:1050-1055.
6. Matthaiou DK, Panos G, Adamidi ES, Falagas ME. 2008. Albendazole versus praziquantel in the treatment of neurocysticercosis: A meta-analysis of comparative trials. PLoS Negl. Trop. Dis. 2:e194. doi:10.1371/journal .pntd.0000194.
7. Nash TE, Garcia HH. 2011. Diagnosis and treatment of neurocysticercosis. Nat. Rev. Neurol. 7:584-594.
8. Lacey E, Prichard RK. 1986. Interactions of benzimidazoles (BZ) with tubulin from BZ-sensitive and BZ-resistant isolates of Haemonchus contortus. Mol. Biochem. Parasitol. 19:171-181.
9. Sotelo J, Jung H. 1998. Pharmacokinetic optimization of the treatment of neurocysticercosis. Clin. Pharmacokinet. 34:503-515.
10. Knight RA, Colglazier ML. 1977. Albendazole as a fasciolicide in experimentally infected sheep. Am. J. Vet. Res. 38:807-808.
11. Liu YJ, Li QZ, Hao YH. 2003. Morphological changes to early stage Taenia solium cysticerci following oxfendazole treatment. Vet. J. 165: 73-77.
12. Takayanagui OM, Bonato PS, Dreossi SA, Lanchote VL. 2002. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis. Br. J. Clin. Pharmacol. 54:125-130.
13. Lourenço TC, Batista JM, Jr, Furlan M, He Y, Nafie LA, Santana CC, Cass QB. 2012. Albendazole sulfoxide enantiomers: Preparative chiral separation and absolute stereochemistry. J. Chromatogr. A 1230:61-65.
14. Lanchote VL, Takayanagui OM, Mateus FH. 2004. Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis. Chirality 16:520-525.
15. Marques MP, Takayanagui OM, Bonato PS, Santos SR, Lanchote VL. 1999. Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis. Chirality 11:218-223.
16. Mahanty S, Paredes A, Marzal M, Gonzalez E, Rodriguez S, Dorny P, Guerra-Giraldez C, Garcia HH, Nash T. 2011. Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts. Antimicrob. Agents Chemother. 55: 211-217.
17. Dorny P, Vercammen F, Brandt J, Vansteenkiste W, Berkvens D, Geerts S. 2000. Sero-epidemiological study of Taenia saginata cysticercosis in Belgian cattle. Vet. Parasitol. 88:43-49.
18. Erhart A, Dorny P, Van De N, Vien HV, Thach DC, Toan ND, Cong le D, Geerts S, Speybroeck N, Berkvens D, Brandt J. 2002. Taenia solium cysticercosis in a village in northern Viet Nam: Seroprevalence study using an ELISA for detecting circulating antigen. Trans. R. Soc. Trop. Med. Hyg. 96:270-272.
19. Rodriguez S, Dorny P, Tsang VC, Pretell EJ, Brandt J, Lescano AG, Gonzalez AE, Gilman RH, Garcia HH. 2009. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J. Infect. Dis. 199:1345-1352.
20. Naguleswaran A, Spicher M, Vonlaufen N, Ortega-Mora LM, Torgerson P, Gottstein B, Hemphill A. 2006. In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus. Antimicrob. Agents Chemother. 50:3770-3778.
21. Stettler M, Siles-Lucas M, Sarciron E, Lawton P, Gottstein B, Hemphill A. 2001. Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone. Antimicrob. Agents Chemother. 45: 2256-2262.
22. Palomares F, Palencia G, Perez R, Gonzalez-Esquivel D, Castro N, Cook HJ. 2004. In vitro effects of albendazole sulfoxide and praziquantel against Taenia solium and Taenia crassiceps cysts. Antimicrob. Agents Chemother. 48:2302-2304.
23. Palomares-Alonso F, Piliado JC, Palencia G, Ortiz-Plata A, Jung-Cook H. 2007. Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts. J. Antimicrob. Chemother. 59:212-218.
24. Garcia-Dominguez C, Correa D, Rabiela MT, Flisser A. 1991. Praziquantel treatment of muscle Taenia solium cysticercosis. 4. Reversible in vitro effect. Parasitol. Res. 77:691-696.
25. Palomares F, Palencia G, Ambrosio JR, Ortiz A, Jung-Cook H. 2006. Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: In vitro studies. J. Antimicrob. Chemother. 57:482-488.
26. Bolás-Fernández F, Rama-Iniguez S, Torrado JJ. 2004. Ex vivo anthelmintic activity of albendazole-sulphoxide enantiomers. J. Parasitol. 90: 407-409.
27. Bao GS, Zhang H, Jing T, Qiao H, Wang J. 2008. In vitro observation on albendazole sulfoxide and its enantiomers against Echinococcus granulosus protoscolex. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 26:459-461, 465. (In Chinese.)
28. Solana HD, Sallovitz JM, Lanusse CE, Rodriguez JA. 2002. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Methods Find. Exp. Clin. Pharmacol. 24:7-13.
29. Alvarez LI, Imperiale FA, Sanchez SF, Murno GA, Lanusse CE. 2000. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet. Parasitol. 94:75-89.
30. Capece BP, Virkel GL, Lanusse CE. 2009. Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: Pharmacological implications. Vet. J. 181:241-250.